share_log

东诚药业:控股子公司获得药物临床试验批准通知书

Gelonghui Finance ·  Apr 28 20:05
格隆汇4月29日|东诚药业公告,控股子公司蓝纳成收到中国国家药监局核准签发的关于177LuLNC1008注射液的药物临床试验批准通知书,将于近期开展临床试验。
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment